What has real-world experience taught us about apremilast that clinical trials alone could not?
Featuring:
Updated:Oct 16, 2026
DermInsider consists of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:Wednesday, November 18, 20268 PM ET / 5 PM PTSession 8: Clinical Practice Planning Pearls
DermInsider consists of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:Wednesday, November 11, 20268 PM ET / 5 PM PTSession 7: “So Many Products, How Do I Choose?” Sorting Through Skin Care and Cosmeceuticals
DermInsider Session 6: EB Evolved: Addressing Unmet Needs in Pediatric Epidermolysis Bullosa with Novel TherapiesIn this 45-minute DermInsider, expert faculty explore unmet treatment needs in pediatric epidermolysis bullosa (EB) and the evolving treatment landscape. Join faculty as they review the latest efficacy data for novel therapies, share real-world clinical pearls, and discuss practical strategies for integrating new treatment options into individualized care for patients with EB.This activity is supported by an educational grant from Chiesi USA, Inc.
DermInsider consists of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:Wednesday, September 23, 20268 PM ET / 5 PM PTSession 5: Modern Management of Vitiligo: Exploring Current and Future Therapies